Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens

被引:1031
作者
Santajit, Sirijan [1 ]
Indrawattana, Nitaya [1 ]
机构
[1] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, 420-6 Rajvithi Rd, Bangkok 10400, Thailand
关键词
EXTENDED-SPECTRUM VARIANT; PSE-2; BETA-LACTAMASE; ANTIBIOTIC-RESISTANCE; STAPHYLOCOCCUS-AUREUS; PSEUDOMONAS-AERUGINOSA; EFFLUX PUMPS; ACINETOBACTER-BAUMANNII; ENTEROCOCCUS-FAECIUM; MULTIDRUG-RESISTANCE; EPIDEMIOLOGY;
D O I
10.1155/2016/2475067
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) are the leading cause of nosocomial infections throughout the world. Most of them are multidrug resistant isolates, which is one of the greatest challenges in clinical practice. Multidrug resistance is amongst the top three threats to global public health and is usually caused by excessive drug usage or prescription, inappropriate use of antimicrobials, and substandard pharmaceuticals. Understanding the resistance mechanisms of these bacteria is crucial for the development of novel antimicrobial agents or other alternative tools to combat these public health challenges. Greater mechanistic understanding would also aid in the prediction of underlying or even unknown mechanisms of resistance, which could be applied to other emerging multidrug resistant pathogens. In this review, we summarize the known antimicrobial resistance mechanisms of ESKAPE pathogens.
引用
收藏
页数:8
相关论文
共 53 条
[1]   Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA) [J].
Appelbaum, Peter C. .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (05) :398-408
[2]   Microbiology of antibiotic resistance in Staphylococcus aureus [J].
Appelbaum, Peter C. .
CLINICAL INFECTIOUS DISEASES, 2007, 45 :S165-S170
[3]   The rise of the Enterococcus: beyond vancomycin resistance [J].
Arias, Cesar A. ;
Murray, Barbara E. .
NATURE REVIEWS MICROBIOLOGY, 2012, 10 (04) :266-278
[4]   What's new in antibiotic resistance? Focus on beta-lactamases [J].
Babic, Maja ;
Hujer, Andrea M. ;
Bonomo, Robert A. .
DRUG RESISTANCE UPDATES, 2006, 9 (03) :142-156
[5]   Epidemiological study of an Acinetobacter baumannii outbreak by using a combination of antibiotyping and ribotyping [J].
Biendo, M ;
Laurans, G ;
Lefebvre, JF ;
Daoudi, F ;
Eb, F .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (07) :2170-2175
[6]  
BODONAIK NC, 1984, W INDIAN MED J, V33, P8
[7]   Growing group of extended-spectrum β-lactamases:: The CTX-M enzymes [J].
Bonnet, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) :1-14
[8]   Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America [J].
Boucher, Helen W. ;
Talbot, George H. ;
Bradley, John S. ;
Edwards, John E., Jr. ;
Gilbert, David ;
Rice, Louis B. ;
Scheld, Michael ;
Spellberg, Brad ;
Bartlett, John .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) :1-12
[9]   Antimicrobial resistance in clinical isolates of Staphylococcus aureus from hospital and community sources in southern Jamaica [J].
Brown, Paul D. ;
Ngeno, Charles .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (03) :220-225
[10]   A FUNCTIONAL CLASSIFICATION SCHEME FOR BETA-LACTAMASES AND ITS CORRELATION WITH MOLECULAR-STRUCTURE [J].
BUSH, K ;
JACOBY, GA ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1211-1233